In late September this year, doctors at Mumbai-based Tata Memorial Centre told Rashmi Pandey, wife of 38-year-old Prakash Kumar Badal who was diagnosed with Stage 4 cancer, that his second line of treatment had failed. They gently advised Rashmi to take him home as there were no options left for him.
Wife being a wife, 35-year-old Rashmi did not sleep that night. After seeing him fighting a rare stage 4 cancer near his pancreas for nearly a year, all her hopes crashed that day. Cut to 31 October, a little over a month later, Prakash took his first tablet of daraxonrasib – a cancer drug that is not sold in India and that the US Food and Drug Administration approved only on 26 August. Yes, Rashmi tracked it down with her relentless Google search, emailing and using the network of her friends, family and past and present colleagues. Eventually she arranged to import it, and friends, family and strangers have paid for it.